Drug Discovery Websites

Armand Cognetta (III) is a scientist interested in human health and well-being. He earned his PhD in Chemical Biology from Scripps Research Institute, where he developed chemo-proteomic platforms and co-authored numerous scientific publications and patents. He then joined Inzen Therapeutics as one of the first employees, building their proteomics drug discovery engine. Currently, Armand is the Founder and CEO of General Proximity, a company developing induced-proximity medicines. In his free time, he enjoys reading, writing, and Type 2 Fun activities.